Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs
OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Patent DocsBiotech/Pharma Docket
By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry
ADVERTISEMENTS
By James DeGiulio -- Abbott and Elan End TriCor Suit with Ranbaxy After only a few months, Abbott Loaboratories and Elan Pharma International, along with Abbott subsidiary Fournier Laboratories, have dropped their patent suit against Ranbaxy Laboratories over the latter's generic version of the cholesterol drug TriCor. The dispute between the companies began in June 2010, when Abbott, Fournier, and Elan brought two suits against Ranbaxy in the U.S. District Court for the District of New Jersey following Ranbaxy's ANDA filing in April for a generic fenofibrate drug (see "Court Report," June 13, 2010). The plaintiffs accused Ranbaxy of infringing...Full post as published by Patent Docs on March 04, 2011 (boomark / email).
Lawsuits and Settlements
Medical Records
To Stay out of Pharma's Hands
Bayer CropScience AG
alleging farmers suffered economic losses after Bayer's biotech Liberty Link rice was released into the food supply and countries banned US rice.
Hormone Replacement Therapy Lawsuits See Multi-Million Dollar Settlements
HRT Lawsuits Pharma Faces Multi Million Dollar Settlements
Related Searches
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.

Upcoming Patent Events: Pharma/Biotech IP Due Diligence
ACI "Pharma/Biotech IP Due Diligence" Conference, New York, January 30-31
Biotech Patents: Strategies for an Evolving Legal Climate
Patent Docs' Weekly Court Report









